ACXP

Acurx Pharmaceuticals, Inc.

Pharmaceutical PreparationsNasdaqNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Total Trades

9

Buys

9

Sells

0

Largest Trade

$50K–$100K

Insiders

6

Institutional Funds

13

Inst. Value

$100K–$500K

Activist Filings

3

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Scodari Joseph CDirectorBUY$15K–$50K25K$1.01Jan 8, 2025
Sailer CarlDirectorBUY$15K–$50K25K$1.01Jan 8, 2025
LUCI DAVID PPresident and CEOBUY$15K–$50K49K$1.01Jan 8, 2025
Donohue James J.DirectorBUY$1K–$15K10K$1.01Jan 8, 2025
DELUCCIA ROBERT JDirectorBUY$15K–$50K49K$1.01Jan 8, 2025
DEAN JACK HDirectorBUY$1K–$15K10K$1.01Jan 8, 2025
Sailer CarlDirectorBUY$50K–$100K20K$3.80Jul 29, 2022
DELUCCIA ROBERT JDirectorBUY$50K–$100K20K$3.80Jul 29, 2022
LUCI DAVID PPresident and CEOBUY$50K–$100K20K$3.80Jul 29, 2022
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 13 funds holding

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

Armistice Capital, LLC

SC 13G/A · Aug 15, 2025

10.0%

1.3M shares

Armistice Capital, LLC

SC 13G/A · Feb 14, 2024

5.0%

723K shares

Armistice Capital, LLC

SC 13G · Feb 14, 2023

7.6%

880K shares

View on Google Finance →